SCHEMBL1634799

SCHEMBL1634799

O=C(O)C(F)(F)S(=O)(=O)[O-].c1ccc([S+](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GPR3 P46089 1/20 0.36
PTPN1 P18031 1/20 0.36
CES1 P23141 2/20 0.34
HSD11B1 P28845 2/20 0.33
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
CA5A P35218 1/20 0.32
CA12 O43570 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
CYP1A2 P05177 2/20 0.31
MEN1 O00255 2/20 0.31
TSHR P16473 2/20 0.31
KMT2A Q03164 2/20 0.31
ABCC9 O60706 1/20 0.31
ABCC8 Q09428 1/20 0.31
KCNJ11 Q14654 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL37032 0.83 GPR3 (0.50) ALDH1A1GPR3PTPN1HSD11B1CA1
Trifluoromethanesulfonic Acid SCHEMBL31155703 0.83 GPR3 (0.50) ALDH1A1GPR3PTPN1HSD11B1CA1
SCHEMBL245132 0.82 GAA (0.43) ALDH1A1L3MBTL1PTPN1SMN1; SMN2CYP1A2
SCHEMBL29745863 0.81 GPR3 (0.40) ALDH1A1GPR3PTPN1CES1HSD11B1
Trifluoromethanesulfonic Acid SCHEMBL10008137 0.81 GPR3 (0.48) GPR3PTPN1HSD11B1CA1CA2
SCHEMBL2437867 0.81 GPR3 (0.40) ALDH1A1GPR3PTPN1CES1HSD11B1
Trifluoromethanesulfonic Acid SCHEMBL6118365 0.81 GPR3 (0.48) GPR3PTPN1HSD11B1CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL3249775 0.80 GPR3 (0.44) GPR3PTPN1CES1HSD11B1CA1
SCHEMBL547386 0.80 KMT2A (0.34) CA1CA2SMN1; SMN2MEN1TSHR
SCHEMBL547232 0.79 KMT2A (0.35) L3MBTL1GPR3PTPN1SMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130137037-A1 Silicon Compound, Condensation Product, Resist Compostion and Pattern Formation Method CENTRAL GLASS COMPANY, LIMITED (JP) 2013-05-30 US disclosed
US-8378016-B2 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-02-19 US disclosed
US-20110165519-A1 RESIN SUITABLE FOR AN ACID GENERATOR AND A CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION CONTAINING THE SAME ANDO NOBUO 2011-07-07 US disclosed
US-7932334-B2 Resin suitable for an acid generator SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-04-26 US disclosed
US-20100203446-A1 CHEMICALLY AMPLIFIED PHOTORESIST COMPOSITION AND METHOD FOR FORMING PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-12 US disclosed
US-20070149702-A1 Resin suitable for an acid generator and a chemically amplified positive resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137037-A1 Silicon Compound, Condensation Product, Resist Compostion and Pattern Formation Method CCNB1, FEM1B, SEM1 ALDH1A1 3473/4885L3MBTL1 2252/4885GPR3 3271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.